不伴代谢相关脂肪性肝病的非酒精性脂肪性肝病与代谢综合征风险
研究随访12,197名无代谢功能障碍的成人,基线时无人符合MAFLD标准,NAFLD患病率为7.6%。随访74,508人年期间2179人发生代谢综合征,NAFLD患者发生代谢综合征的风险比为1.61(95%CI 1.42-1.83)。结论认为无MAFLD的NAFLD者代谢综合征风险仍升高,仅用MAFLD标准可能错过早期干预机会。
要点
- 在无代谢功能障碍且无显著饮酒的人群中,NAFLD患病率为7.6%。
- NAFLD患者发生代谢综合征的风险比为1.61(95%CI 1.42-1.83)。
- 腰围增高者(交互P=.029)和无甘油三酯升高者(交互P=.047)中关联更强。
核心结论
- 在无MAFLD的NAFLD参与者中,发生代谢综合征的风险高于无NAFLD且无MAFLD的参与者。
- 使用MAFLD标准可能错过这些受试者的早期干预机会。
研究设计与样本
- 研究随访了12,197名20岁及以上、无代谢功能障碍(按MAFLD标准定义)、无大量饮酒、无慢性病毒性肝炎、无肝硬化或无恶性肿瘤的男性和女性,观察其发生代谢综合征(按成人治疗组III标准定义)的风险。
主要发现
- 在符合MAFLD标准无代谢功能障碍且无显著饮酒的参与者中,NAFLD患病率为7.6%。
- 随访74,508人年期间,2179名参与者发生代谢综合征。
- 比较NAFLD参与者与无NAFLD参与者,完全校正的代谢综合征风险比为1.61(95%CI 1.42-1.83)。
- NAFLD与代谢综合征风险的关联在所有研究亚组中持续存在,在腰围增高者中关联更强(交互P=.029),在无甘油三酯升高者中关联更强(交互P=.047)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Metabolic (dysfunction)-associated fatty liver disease (MAFLD) was proposed to replace nonalcoholic fatty liver disease (NAFLD). Some people fulfill diagnostic criteria of NAFLD but not MAFLD (NAFLD without MAFLD), but the clinical implications of NAFLD in these subjects is unknown. METHODS: We followed cohort of 12,197 men and women 20 years of age or older without metabolic dysfunction (defined by MAFLD criteria), heavy alcohol use, chronic viral hepatitis, liver cirrhosis, or malignancy for their risk of incident metabolic syndrome defined by Adult Treatment Panel III criteria. RESULTS: By design, none of the study participants had MAFLD at baseline. The prevalence of NAFLD among participants without metabolic dysfunction meeting MAFLD criteria and without significant alcohol intake was 7.6%. During 74,508 person-years of follow-up, 2179 participants developed metabolic syndrome. The fully adjusted hazard ratio for metabolic syndrome comparing participants with NAFLD to those without it was 1.61 (95% confidence interval, 1.42-1.83). The increased risk of incident metabolic syndrome associated with NAFLD persisted for all studied subgroups, and the association was stronger for those with increased waist circumference (P for interaction = .029) and those without elevated triglycerides levels (P for interaction = .047). CONCLUSION: In this large cohort, participants with NAFLD without MAFLD were at higher risk of developing metabolic syndrome compared to participants with no NAFLD and no MAFLD. Using MAFLD criteria may miss opportunities for early intervention in these subjects.
引用
- Sinn DH, Kang D, Choi SC, et al. Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome. Clin Gastroenterol Hepatol. 2022. PMID: 36152895. doi:10.1016/j.cgh.2022.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。